Von Willebrand Disease (VWD)
Part 1:
NHLBI Diagnosis Guidelines
Introduction & Clinical Assessment Recommendations
Methodology
May 2011
VWD and VWF published literature and studies were identified and categorized into hierarchical categories for level of evidence, with randomized controlled trials (and meta-analyses of them) ranked the highest (levels Ia and Ib), whereas information reflecting the opinions of experts was ranked lowest (evidence level IV).
Methodology |
Jump to section:
- Introduction
- Objectives — Part 1
- VWF Biology
- VWF and Normal Hemostasis1
- VWF Structure and Domains1
- VWD Classification — ISTH1,2
- VWD: Prevalence, Inheritance, Symptoms
- Disorders Pathophysiologically Associated with Acquired von Willebrand Syndrome (AVWS)3
- VWD NHLBI Guidelines — Background
- NHLBI VWD Expert Panel
- Methodology
- Methodology
- Overall Outcome / Results
- Initial Clinical Evaluation for VWD or Other Bleeding Disorders1
- Common Bleeding Symptoms of Healthy Persons vs. VWD Patients1
- VWD NHLBI Guidelines (2008)1Initial Patient Evaluation — History4
- VWD NHLBI Guidelines (2008) Initial Patient Evaluation — History
- Initial Patient Evaluation — History
- VWD NHLBI Guidelines (2008)
- References
- Questions?
External
link
PDF
document
Excel
document
Word
document